Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy.
Amniotic membrane
Blood disorders
Graft-versus-host disease
Leukemia
Wound healing
Journal
Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334
Informations de publication
Date de publication:
06 Sep 2024
06 Sep 2024
Historique:
received:
28
04
2024
accepted:
02
09
2024
medline:
6
9
2024
pubmed:
6
9
2024
entrez:
5
9
2024
Statut:
aheadofprint
Résumé
Allogeneic hematopoietic stem cell transplantation (alloSCT) is the cornerstone treatment for various hematopoietic disorders, but its utility is often compromised by chronic graft-versus-host disease (cGvHD), affecting skin integrity and leading to ulcer formations. Traditional treatments, including systemic and topical therapies, frequently fail in severe cases. This study retrospectively examines three patients with therapy-resistant ulcers due to cGvHD post-alloSCT treated at the University Hospital of Regensburg in 2023. We evaluated the therapeutic impact of human amniotic membrane (hAM) transplantation-a novel approach utilizing hAM's anti-inflammatory, anti-microbial, and anti-fibrotic properties for wound healing. Surgical debridement was followed by hAM application and routine follow-up. HAM transplantation led to complete wound closure in two out of three patients and a significant reduction in local pain and infection rates. The treatment alleviated the need for regular dressing changes within three months in two patients, demonstrating the hAM's efficacy in fostering rapid and sustained healing. The utilization of hAM represents a promising alternative for the management of refractory skin ulcers in cGvHD patients, particularly when conventional methods are inadequate.
Identifiants
pubmed: 39237815
doi: 10.1007/s00277-024-05990-8
pii: 10.1007/s00277-024-05990-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354(17):1813–1826. https://doi.org/10.1056/NEJMra052638
doi: 10.1056/NEJMra052638
pubmed: 16641398
Gratwohl A, Brand R, Niederwieser D et al (2011) Introduction of a Quality Management System and Outcome after hematopoietic stem-cell transplantation. J Clin Oncol 29(15):1980–1986. https://doi.org/10.1200/JCO.2010.30.4121
doi: 10.1200/JCO.2010.30.4121
pubmed: 21483006
Lee SJ, Vogelsang G, Flowers MED (2003) Chronic graft-versus-host disease. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl 9(4):215–233. https://doi.org/10.1053/bbmt.2003.50026
doi: 10.1053/bbmt.2003.50026
Jagasia MH, Greinix HT, Arora M et al (2015) National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging Working Group Report. Biol Blood Marrow Transpl 21(3):389–401e1. https://doi.org/10.1016/j.bbmt.2014.12.001
doi: 10.1016/j.bbmt.2014.12.001
Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373(9674):1550–1561. https://doi.org/10.1016/S0140-6736(09)60237-3
doi: 10.1016/S0140-6736(09)60237-3
pubmed: 19282026
pmcid: 2735047
Lamby P, Wolff D, Mielke S et al (2019) Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients. Ann Hematol 98(8):1867–1875. https://doi.org/10.1007/s00277-019-03687-x
doi: 10.1007/s00277-019-03687-x
pubmed: 30993415
Jirsova K, Jones GLA (2017) Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting—a review. Cell Tissue Bank 18(2):193–204. https://doi.org/10.1007/s10561-017-9618-5
doi: 10.1007/s10561-017-9618-5
pubmed: 28255771
Ilic D, Vicovac L, Nikolic M, Lazic Ilic E (2016) Human amniotic membrane grafts in therapy of chronic non-healing wounds: table 1. Br Med Bull 117(1):59–67. https://doi.org/10.1093/bmb/ldv053
doi: 10.1093/bmb/ldv053
pubmed: 26764358
Cooke KR, Luznik L, Sarantopoulos S et al (2017) The Biology of Chronic Graft-versus-host disease: a Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transpl 23(2):211–234. https://doi.org/10.1016/j.bbmt.2016.09.023
doi: 10.1016/j.bbmt.2016.09.023
Croudace JE, Inman CF, Abbotts BE et al (2012) Chemokine-mediated tissue recruitment of CXCR3 + CD4 + T cells plays a major role in the pathogenesis of chronic GVHD. Blood 120(20):4246–4255. https://doi.org/10.1182/blood-2012-02-413260
doi: 10.1182/blood-2012-02-413260
pubmed: 23012327
Ammer J, Prantl L, Holler B et al (2012) Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor. Bone Marrow Transpl 47(10):1368–1369. https://doi.org/10.1038/bmt.2012.16
doi: 10.1038/bmt.2012.16
Baradaran-Rafii A MD1; Hamid-Reza Aghayan, MD2; Babak Arjmand, MD2; Mohammad-Ali Javadi, MD1. Amniotic membrane transplantation. Published online 2007.